Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

Stopped early · Phase 2/Phase 3

Conditions studied: Dementia With Lewy Bodies

In brief

This 6-month extension study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) in subjects with Dementia with Lewy bodies (DLB) who have participated in the double-blind, placebo-controlled, lead-in study RVT-101-2001.

Key facts

Study ID
NCT02928445
Run by
Axovant Sciences Ltd.
People needed
240
Starts
2016-10-01
Expected to finish
2018-02-01
Last updated by the study team
2018-04-18

Who can join

Age: 50 and older, up to 86. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.